About AviGen
AviGen is a Healthcare company based in Alameda (United States) founded in 1992, and was acquired by MediciNova in February 2009. Gene therapy products are developed for inherited and acquired diseases. Its focus areas include Life Sciences, Rare Diseases, Drugs and Diversified. Its competitors include Moderna, BridgeBio and Spark Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 1992 and based in Alameda, United States, operations are focused on biotechnology, specifically gene therapy for diseases such as cancer, anemia, hemophilia, hyperlipidemia, and metabolic storage disorders. Proprietary technologies including AAV vectors and the Targeted Vector Integration system are utilized to deliver genes. Treatments for blood cell-related conditions like sickle cell anemia, beta-thalassemia, and HIV infection are also advanced.
- Headquarters Alameda, United States
- Stage Acquired
- SectorsHealthcare
- Website avigen.com
- Acquired by MediciNova (Feb 2009)
- Investors
- Acquired byMediciNova
(Feb 2009)
Investors in AviGen
AviGen has secured backing from 1 investor. Prominent investors backing the company include MediciNova.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases. | 2000 | medicinova.com | San Diego, United States |
Investor details for AviGen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of AviGen
2 dated milestones of AviGen across 17 years, from founding to its latest funding, stage changes and deals.
- Founded AviGen is founded.
- Exit Acquired by MediciNova.
Competitors of AviGen
AviGen has 3 listed competitors in our database, 3 of them funded. They include Moderna, BridgeBio and Spark Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | Therapeutics for genetic diseases are developed through targeted interventions. | ||
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. |
Detailed competitors of AviGen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as AviGen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AviGen
AviGen was founded in 1992.
AviGen is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
Founded in 1992 and based in Alameda, United States, operations are focused on biotechnology, specifically gene therapy for diseases such as cancer, anemia, hemophilia, hyperlipidemia, and metabolic storage disorders. Proprietary technologies including AAV vectors and the Targeted Vector Integration system are utilized to deliver genes. Treatments for blood cell-related conditions like sickle cell anemia, beta-thalassemia, and HIV infection are also advanced.
AviGen's top competitors include Moderna, Spark Therapeutics and BridgeBio.
AviGen has 1 investor. Key investors include MediciNova.
Yes. AviGen was acquired by MediciNova in February 2009.
